Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001641172-25-014752
Filing Date
2025-06-11
Accepted
2025-06-11 17:30:04
Documents
16

Document Format Files

Seq Description Document Type Size
1 S-1 forms-1.htm S-1 884644
2 EX-5.1 ex5-1.htm EX-5.1 19033
3 EX-23.1 ex23-1.htm EX-23.1 2525
4 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 57339
5 GRAPHIC forms-1_001.jpg GRAPHIC 3034
6 GRAPHIC ex5-1_001.jpg GRAPHIC 15653
  Complete submission text file 0001641172-25-014752.txt   1131078

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 11206
Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-287963 | Film No.: 251040999
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)